New shot could train body to tolerate peanuts
NCT ID NCT07349212
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new injection called UKK-0018 for people with peanut allergies. The goal is to train the immune system to handle peanut exposure without a severe reaction. The trial involves 40 adults aged 18-55 and will first check safety, then see if it helps increase the amount of peanut protein they can tolerate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
UKK-0018 (an immunotherapeutic injection)
What this could lead to
If it works, this could lead to a treatment that reduces the risk of severe allergic reactions to peanuts, making accidental exposure less dangerous.
What could go wrong
This is a very early Phase 1/2 trial with only 40 people, so safety and effectiveness are not yet proven. It may not work for everyone, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Xolair for Peanut Allergy Study (NCT00382148)
- Biologics for Multi-Food Allergy OIT (NCT03679676)
- MOON101 Peanut Allergy Safety Trial (NCT07580898)
- NATASHA Study: Using everyday foods for allergy NCT05503446
- ENP-501 Peanut Allergy Trial Phase 1/2 (NCT07117669)
- FMT for Peanut Allergy Trial (NCT02960074)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fiona Stanley Hospital
NOT_YET_RECRUITINGPerth, Western Australia, 6150, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Flinders Medical Center
NOT_YET_RECRUITINGBedford Park, South Australia, 5042, Australia
Contact Email: •••••@•••••
-
Pacific Clinical Research Network - Auckland
RECRUITINGTakapuna, Auckland, 0622, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Royal Prince Alfred Hospital
NOT_YET_RECRUITINGCamperdown, New South Wales, 2050, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Royal Melbourne Hospital
RECRUITINGFitzroy, Victoria, 3065, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••